Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Clinical ocular toxicology : drugs, chemicals and herbs / Frederick T. Fraunfelder, Frederick W. Fraunfelder , Wiley A. Chambers
| Clinical ocular toxicology : drugs, chemicals and herbs / Frederick T. Fraunfelder, Frederick W. Fraunfelder , Wiley A. Chambers |
| Autore | Fraunfelder, Frederick T. |
| Pubbl/distr/stampa | Philadelphia : Elsevier Saunders, c2008 |
| Descrizione fisica | xii, 370 p. : ill. color. ; 28 cm |
| Disciplina | 615/.78 |
| Altri autori (Persone) |
Fraunfelder, Frederick W.
Chambers, Wiley A. |
| Soggetto topico |
Ocular toxicology - Handbooks, manuals, etc
Ocular pharmacology - Handbooks, manuals, etc Drugs - Side effects - Handbooks, manuals, etc Eye - drug effects - Handbooks Drug Interactions - Handbooks Drug Therapy - Adverse effects - Handbooks Iatrogenic Disease - Handbooks |
| ISBN | 9781416046738 |
| Classificazione |
LC RE901.T67
53.9.78 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISALENTO-991003908649707536 |
Fraunfelder, Frederick T.
|
||
| Philadelphia : Elsevier Saunders, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. del Salento | ||
| ||
Clinical trials in psychopharmacology [[electronic resource] ] : a better brain / / editors, Marc Hertzman, Lawrence Adler
| Clinical trials in psychopharmacology [[electronic resource] ] : a better brain / / editors, Marc Hertzman, Lawrence Adler |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : J. Wiley, 2010 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina | 615/.78 |
| Altri autori (Persone) |
HertzmanMarc
AdlerLawrence |
| Soggetto topico |
Psychopharmacology
Psychotropic drugs Clinical trials |
| ISBN |
1-282-54816-6
9786612548161 0-470-74918-0 0-470-74917-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Trials in Psychopharmacology; Contents; Acknowledgments; Introduction; List of Contributors; SECTION I: The Health Care Environment and Medications; 1. FDA Reform: D ́ej`a vu Encore; 1.1 Introduction; 1.2 The 1992 prescription drug user fee act adds funds and changes FDA's focus; 1.3 PDUFA shortens drug review times and eliminates the drug lag; 1.4 PDUFA timetables feed safety concerns; 1.5 FDA responds to safety concerns; 1.6 The pipeline problem; 1.7 The 2007 FDA Science Board's Subcommittee on Science and Technology report
1.8 The FDAAA of 2007 reauthorize PDUFA and provide new authority to address safety and the critical path initiative1.9 The impact of PDFUA on FDA; 1.10 Comparative medical benefits, comparative effectiveness and FDA; 1.11 FDA and non-inferiority trials; 1.12 FDA and CMS decisions on Medicare coverage; 1.13 Preemption: FDA's role in relation to liability litigation in state courts; 1.14 FDA's exclusivity in allowing access to experimental drugs; 1.15 Conclusions; 2. Do Antidepressants Cause Suicide?; 2.1 Some definitional problems 2.2 A brief history of the concerns of suicidality caused by antidepressants2.3 Politics rears its ugly head; 2.4 The FDA responds; 2.5 What changes in public policy wrought; 2.6 A funny thing happened on the way to the forum; 2.7 Meanwhile back at the ranch; 2.8 Moral (maybe); 3. The Genome, Genes and Brain - Tailored Drugs; 3.1 Introduction; 3.2 Issues in new drug development; 3.3 Early development of psychiatric pharmaceutical entities; 3.4 Advances in research technology; 3.5 Review of genetics; 3.6 Activation of genes by signal transduction cascades; 3.7 The human genome 3.8 The sequencing of the genome3.9 DNA variation; 3.10 Genes and illness; 3.11 Genomic findings, potential targets and new drug development; 3.12 Conclusion; 4. Patenting and Licensing Concerns in Psychiatric Genetics; 4.1 Genetic diagnoses in psychiatry; 4.2 The evolving patent landscape in psychiatry; 4.3 Approaches to solving potential problems; 4.4 Conclusions; 5. Women's Issues in Clinical Trials; 5.1 History; 5.2 Perceived advantages of excluding women; 5.3 Change in perspective; 5.4 Have things changed?; 5.5 Progress since 1993; 5.6 Reported current difficulties in including women 5.7 Contraception in clinical trials5.8 Drugs in lactating women; 5.9 How often do women take drugs during pregnancy?; 5.10 Ethical issues: risk/benefit analysis; 5.11 Adequate information; 5.12 Adolescent women; 5.13 Recruitment and retention of women; SECTION II: Clinical Trials and Mood Disorders; 6. Issues and Clues in the Pharmacological Treatment of Mood Disorders; 6.1 What do we know about mood disorders that may be relevant for their pharmacological treatment?; 6.2 Are there clues for the pharmacological treatment of mood disorders?; 6.3 Perspectives; 7. Bipolar Disorder 7.1 Introduction |
| Record Nr. | UNINA-9910139427703321 |
| Chichester, West Sussex ; ; Hoboken, NJ, : J. Wiley, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical trials in psychopharmacology [[electronic resource] ] : a better brain / / editors, Marc Hertzman, Lawrence Adler
| Clinical trials in psychopharmacology [[electronic resource] ] : a better brain / / editors, Marc Hertzman, Lawrence Adler |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : J. Wiley, 2010 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina | 615/.78 |
| Altri autori (Persone) |
HertzmanMarc
AdlerLawrence |
| Soggetto topico |
Psychopharmacology
Psychotropic drugs Clinical trials |
| ISBN |
1-282-54816-6
9786612548161 0-470-74918-0 0-470-74917-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Trials in Psychopharmacology; Contents; Acknowledgments; Introduction; List of Contributors; SECTION I: The Health Care Environment and Medications; 1. FDA Reform: D ́ej`a vu Encore; 1.1 Introduction; 1.2 The 1992 prescription drug user fee act adds funds and changes FDA's focus; 1.3 PDUFA shortens drug review times and eliminates the drug lag; 1.4 PDUFA timetables feed safety concerns; 1.5 FDA responds to safety concerns; 1.6 The pipeline problem; 1.7 The 2007 FDA Science Board's Subcommittee on Science and Technology report
1.8 The FDAAA of 2007 reauthorize PDUFA and provide new authority to address safety and the critical path initiative1.9 The impact of PDFUA on FDA; 1.10 Comparative medical benefits, comparative effectiveness and FDA; 1.11 FDA and non-inferiority trials; 1.12 FDA and CMS decisions on Medicare coverage; 1.13 Preemption: FDA's role in relation to liability litigation in state courts; 1.14 FDA's exclusivity in allowing access to experimental drugs; 1.15 Conclusions; 2. Do Antidepressants Cause Suicide?; 2.1 Some definitional problems 2.2 A brief history of the concerns of suicidality caused by antidepressants2.3 Politics rears its ugly head; 2.4 The FDA responds; 2.5 What changes in public policy wrought; 2.6 A funny thing happened on the way to the forum; 2.7 Meanwhile back at the ranch; 2.8 Moral (maybe); 3. The Genome, Genes and Brain - Tailored Drugs; 3.1 Introduction; 3.2 Issues in new drug development; 3.3 Early development of psychiatric pharmaceutical entities; 3.4 Advances in research technology; 3.5 Review of genetics; 3.6 Activation of genes by signal transduction cascades; 3.7 The human genome 3.8 The sequencing of the genome3.9 DNA variation; 3.10 Genes and illness; 3.11 Genomic findings, potential targets and new drug development; 3.12 Conclusion; 4. Patenting and Licensing Concerns in Psychiatric Genetics; 4.1 Genetic diagnoses in psychiatry; 4.2 The evolving patent landscape in psychiatry; 4.3 Approaches to solving potential problems; 4.4 Conclusions; 5. Women's Issues in Clinical Trials; 5.1 History; 5.2 Perceived advantages of excluding women; 5.3 Change in perspective; 5.4 Have things changed?; 5.5 Progress since 1993; 5.6 Reported current difficulties in including women 5.7 Contraception in clinical trials5.8 Drugs in lactating women; 5.9 How often do women take drugs during pregnancy?; 5.10 Ethical issues: risk/benefit analysis; 5.11 Adequate information; 5.12 Adolescent women; 5.13 Recruitment and retention of women; SECTION II: Clinical Trials and Mood Disorders; 6. Issues and Clues in the Pharmacological Treatment of Mood Disorders; 6.1 What do we know about mood disorders that may be relevant for their pharmacological treatment?; 6.2 Are there clues for the pharmacological treatment of mood disorders?; 6.3 Perspectives; 7. Bipolar Disorder 7.1 Introduction |
| Record Nr. | UNINA-9910813016803321 |
| Chichester, West Sussex ; ; Hoboken, NJ, : J. Wiley, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
CNS Aging and Its Neuropharmacology : : Experimental and Clinical Aspects / / editor, W. Meier-Ruge
| CNS Aging and Its Neuropharmacology : : Experimental and Clinical Aspects / / editor, W. Meier-Ruge |
| Autore | Meier-Ruge W |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1979 |
| Descrizione fisica | 1 online resource (VIII + 220 pages) : : 45 figures, 30 tables |
| Disciplina |
362.6 s
615/.78 |
| Altri autori (Persone) | Meier-RugeW (William) |
| Collana | Interdisciplinary Topics in Gerontology and Geriatrics |
| Soggetto topico |
Gerontology / Geriatrics
Neurobiology Neurology Neurosurgery Preventive Medicine Psychiatry Social Medicine |
| ISBN | 3-318-03735-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910157468103321 |
|
Meier-Ruge W
|
||
| Basel : , : S. Karger, , 1979 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug-induced ocular side effects / Frederick T. Fraunfelder, Frederick W. Fraunfelder, Wiley A. Chambers ; associate editor Bree Jensvold-Vetsch
| Drug-induced ocular side effects / Frederick T. Fraunfelder, Frederick W. Fraunfelder, Wiley A. Chambers ; associate editor Bree Jensvold-Vetsch |
| Autore | Fraunfelder, Frederick T. |
| Edizione | [7th ed.] |
| Pubbl/distr/stampa | New York ; Philadelphia : Elsevier Saunders, 2015 |
| Descrizione fisica | xi, 411 p. : ill. ; 29 cm |
| Disciplina | 615/.78 |
| Altri autori (Persone) |
Fraunfelder, Frederick W.
Chambers, Wiley A. Jensvold Vetsch, Bree |
| Soggetto topico |
Ocular pharmacology
Drugs - Side effects Drug interactions |
| ISBN | 9780323319843 |
| Classificazione |
LC RE994
617.7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISALENTO-991002814899707536 |
|
Fraunfelder, Frederick T.
|
||
| New York ; Philadelphia : Elsevier Saunders, 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. del Salento | ||
| ||
Drugs and Ocular Tissues : : 2nd Meeting of the International Society for Eye Research, Jerusalem, September 1976: Proceedings / / editor, S. Dikstein
| Drugs and Ocular Tissues : : 2nd Meeting of the International Society for Eye Research, Jerusalem, September 1976: Proceedings / / editor, S. Dikstein |
| Autore | Dikstein S |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1977 |
| Descrizione fisica | 1 online resource (XX + 662 pages) : : 123 figures, 21 tables |
| Disciplina | 615/.78 |
| Altri autori (Persone) | DiksteinS |
| Soggetto topico |
Ophthalmology
Metabolism Pharmaceutics Pharmacology Biochemistry Cell Biology Molecular Biology Physiology |
| ISBN | 3-318-04644-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910148812303321 |
|
Dikstein S
|
||
| Basel : , : S. Karger, , 1977 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs of abuse
| Drugs of abuse |
| Autore | Wills Simon |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | [Place of publication not identified], : Pharmaceutical Press, 2005 |
| Descrizione fisica | 1 online resource (416 pages) |
| Disciplina | 615/.78 |
| Soggetto topico |
Drugs of abuse
Pharmaceutical Preparations Diseases Mental Disorders Substance-Related Disorders Street Drugs Psychiatry and Psychology Chemicals and Drugs Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN | 0-85711-117-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Prelims -- Contents -- Preface -- Acknowledgements -- About the author -- Chapter 1 - Introduction -- The global problem -- Concepts -- Withdrawing drugs in dependence -- Methods of administration -- Drug abuse environments -- Legalisation -- References -- Chapter 2 - Injection of drugs -- Infection -- Irritant effects -- Emboli, blood vessel occlusion and thrombosis -- Pharmacological effects -- 'Stigmata' -- References -- Chapter 3 - Opioids -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Opioid dependence -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 4 - Cannabis -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Abuse and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 5 - Cocaine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 6 - Amfetamine, metamfetamine, ecstasy and related drugs -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Other amfetamine derivatives -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 7 - LSD -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Abuse and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 8 - Gamma hydroxybutyrate -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology.
Adverse effects -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- References -- Chapter 9 - Phencyclidine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- References -- Chapter 10 - Volatile substance abuse -- History -- Effects sought -- Administration -- Pharmacokinetics -- Adverse effects -- Long-term use -- Pregnancy and breastfeeding -- Reducing the abuse problem -- References -- Chapter 11 - Performance-enhancing drugs -- Anabolic-androgenic steroids -- Androgenic-anabolic steroid precursors -- Analgesics -- Beta-blockers -- Clenbuterol -- Diltiazem -- Diuretics -- Erythropoietin -- Nutritional supplements -- References -- Chapter 12 - Prescription drugs -- Anaesthetics -- Antidepressants -- Antimuscarinic drugs -- Sedatives -- Other drugs -- References -- Chapter 13 - Over-the-counter products -- Extent of the problem -- Sympathomimetics -- Dextromethorphan -- Opioid-containing preparations -- Analgesics -- Antihistamines -- Laxatives -- Miscellaneous OTC preparations -- Illicit drug manufacture -- Controlling the problem -- References -- Chapter 14 - Caffeine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Caffeine dependence and withdrawal -- Interaction with medicines -- Pregnancy and breastfeeding -- References -- Chapter 15 - Tobacco -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Interaction with medicines -- Pregnancy and breastfeeding -- References -- Chapter 16 - Alcohol -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Alcohol withdrawal -- Maintaining abstinence -- Interactions with medicines -- Pregnancy and breastfeeding -- References. Chapter 17 - Plants and fungi -- Ayahuasca -- Betel -- Caffeine-containing plants -- Ephedra -- Ginseng -- Kava -- Khat -- Morning glory -- Mushrooms -- Nutmeg -- Peyote cactus -- Potato family -- Salvia divinorum -- Yohimbe -- References -- Chapter 18 - Alkyl nitrites -- History -- Administration -- Effects sought -- Adverse effects -- Drug interactions -- Pregnancy and breastfeeding -- References -- Chapter 19 - Smart drugs -- Abuse liability -- Availability -- Development of smart drugs -- Claims made for smart drugs -- Modes of action -- Future use of smart drugs -- References -- Chapter 20 - Substance misuse and the Internet -- General websites -- Specific topics -- User-oriented sites -- References -- Appendix A - Glossary of street terminology -- Appendix B - Legal status of drugs in the UK -- 1. Misuse of Drugs Act (1971) -- 2. Misuse of Drugs Regulations (updated 2001) -- Drugs not covered -- Index. |
| Record Nr. | UNINA-9910164945703321 |
|
Wills Simon
|
||
| [Place of publication not identified], : Pharmaceutical Press, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Effects of Drugs on Human Functioning / / editors, S. Streufert, F.M. Gengo
| Effects of Drugs on Human Functioning / / editors, S. Streufert, F.M. Gengo |
| Autore | Streufert S |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1993 |
| Descrizione fisica | 1 online resource (XII + 184 pages) : : 6 figures, 8 tables |
| Disciplina | 615/.78 |
| Altri autori (Persone) |
StreufertSiegfried
GengoFrancis |
| Collana | Progress in Basic and Clinical Pharmacology |
| Soggetto topico |
Pharmacology
Pharmaceutics Psychology Behavioral Research Cardiovascular System Gerontology / Geriatrics Neurology Pediatrics Psychiatry Respiratory System |
| ISBN | 3-318-04090-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910158697803321 |
|
Streufert S
|
||
| Basel : , : S. Karger, , 1993 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Genetics and Psychopharmacology / / editor, J. Mendlewicz
| Genetics and Psychopharmacology / / editor, J. Mendlewicz |
| Autore | Mendlewicz J |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1975 |
| Descrizione fisica | 1 online resource (VIII + 132 pages) : : 15 figures, 25 tables |
| Disciplina |
616.8/918/08 s
615/.78 |
| Altri autori (Persone) |
WinokurGeorge
MendlewiczJ (Julien) |
| Soggetto topico |
Psychiatry
Genetics Metabolism Pharmaceutics Pharmacology |
| ISBN | 3-318-03965-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910158725103321 |
|
Mendlewicz J
|
||
| Basel : , : S. Karger, , 1975 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neurobiology of Drug Abuse / / editor, J. Marwah
| Neurobiology of Drug Abuse / / editor, J. Marwah |
| Autore | Marwah J |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1987 |
| Descrizione fisica | 1 online resource (VIII + 164 pages) : : 5 figures, 4 tables |
| Disciplina | 615/.78 |
| Altri autori (Persone) | MarwahJ. <1952-> |
| Soggetto topico |
Neurology
Pharmacology Physiology Psychiatry |
| ISBN | 3-318-03681-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910157657103321 |
|
Marwah J
|
||
| Basel : , : S. Karger, , 1987 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
